Accession Number: | 0001104659-19-005522 |
Date: | 2019-01-31 |
Issuer: | NABRIVA THERAPEUTICS PLC (NBRV) |
Original Submission Date: |
SENDER GARY
1000 CONTINENTAL DRIVE
SUITE 600
KING OF PRUSSIA, PA 19406
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTIONS | 0.0 | 2019-01-31 | deemed execution date | A | 138,200 (a) | 2029-01-31 | ordinary shares 138,200 | $0.00 | 138,200 | direct | ||
RESTRICTED STOCK UNITS | 0.0 | 2019-01-31 | deemed execution date | A | 52,500 (a) | 2023-01-31 | ordinary shares 52,500 | $0.00 | 52,500 | direct |
ID | footnote |
---|---|
f1 | the exercise price is $1.90 per share. |
f2 | this option was granted on january 31, 2019. vesting began on january 31, 2019 and ends on january 31, 2023. twenty-five percent (25%) of the option award will vest on the one (1) year anniversary of the date of grant, and the remaining seventy-five percent (75%) of the option award will vest on a monthly pro-rata basis over the remaining vesting period. |
f3 | the restricted stock unit shall convert into ordinary shares on a one-for-one basis upom vesting of the units. |
f4 | the restricted stock unit award was granted on january 31, 2019. vesting began on january 31, 2019 and ends on january 31, 2023. twenty-five percent (25%) of the restricted stock unit award will vest on the one (1) year anniversary of the date of grant, and the remaining seventy-five percent (75%) of the restricted stock unit award will vest on a monthly pro-rata basis over the remaining vesting period. |